Prothena (NASDAQ:PRTA) used its fourth-quarter and full-year 2025 results call to highlight partner-driven clinical momentum, updates from its wholly owned preclinical portfolio, and a sharper cash ...
Coeur Mining (NYSE:CDE) executives highlighted record fourth-quarter and full-year 2025 results on the company’s earnings call, pointing to stronger production across the portfolio, higher realized ...